Cargando...

A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer’s disease

Clinical trial outcomes for Alzheimer’s disease are typically analyzed by using the mixed model for repeated measures (MMRM) or similar models that compare an efficacy scale change from baseline between treatment arms with or without participants’ disease stage as a covariate. The MMRM focuses on a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Stat Med
Autores principales: Wang, Guoqiao, Berry, Scott, Xiong, Chengjie, Hassenstab, Jason, Quintana, Melanie, McDade, Eric M., Delmar, Paul, Vestrucci, Matteo, Sethuraman, Gopalan, Bateman, Randall J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6105413/
https://ncbi.nlm.nih.gov/pubmed/29761523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.7811
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!